Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

BACKGROUND: Antifungal prophylaxis with a new oral tablet formulation of posaconazole may be beneficial to patients at high risk for invasive fungal disease. A two-part (Phase 1B/3) study evaluated posaconazole tablet pharmacokinetics (PK) and safety. METHODS: Patients with neutropenia following che...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Cornely, Oliver A., Duarte, Rafael F., Haider, Shariq, Chandrasekar, Pranatharthi, Helfgott, David, Jiménez, Javier López, Candoni, Anna, Raad, Issam, Laverdiere, Michel, Langston, Amelia, Kartsonis, Nicholas, Van Iersel, Marlou, Connelly, Nancy, Waskin, Hetty
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937013/
https://ncbi.nlm.nih.gov/pubmed/26612870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkv380
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados